ATE221084T1 - Neuer megakaryocyten-verstärker - Google Patents
Neuer megakaryocyten-verstärkerInfo
- Publication number
- ATE221084T1 ATE221084T1 AT93900384T AT93900384T ATE221084T1 AT E221084 T1 ATE221084 T1 AT E221084T1 AT 93900384 T AT93900384 T AT 93900384T AT 93900384 T AT93900384 T AT 93900384T AT E221084 T1 ATE221084 T1 AT E221084T1
- Authority
- AT
- Austria
- Prior art keywords
- amplifier
- megakaryocyte
- meg
- pot
- new
- Prior art date
Links
- 210000003593 megakaryocyte Anatomy 0.000 title abstract 2
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 abstract 1
- KTSZUNRRYXPZTK-BQBZGAKWSA-N Gly-Gln-Glu Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KTSZUNRRYXPZTK-BQBZGAKWSA-N 0.000 abstract 1
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 abstract 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 108010049041 glutamylalanine Proteins 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 108010061238 threonyl-glycine Proteins 0.000 abstract 1
- 206010043554 thrombocytopenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Amplifiers (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP36152291 | 1991-12-27 | ||
| JP12251892 | 1992-03-31 | ||
| PCT/JP1992/001689 WO1993013132A1 (fr) | 1991-12-27 | 1992-12-24 | Nouvel amplificateur de megakaryocytes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE221084T1 true ATE221084T1 (de) | 2002-08-15 |
Family
ID=26459624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93900384T ATE221084T1 (de) | 1991-12-27 | 1992-12-24 | Neuer megakaryocyten-verstärker |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5498698A (enExample) |
| EP (1) | EP0621285B1 (enExample) |
| JP (1) | JP3328341B2 (enExample) |
| KR (1) | KR100233701B1 (enExample) |
| CN (1) | CN1075148A (enExample) |
| AT (1) | ATE221084T1 (enExample) |
| AU (1) | AU658040B2 (enExample) |
| CA (1) | CA2126680C (enExample) |
| DE (1) | DE69232698T2 (enExample) |
| ES (1) | ES2180542T3 (enExample) |
| TW (1) | TW224975B (enExample) |
| WO (1) | WO1993013132A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107366A (en) * | 1992-10-23 | 2003-03-12 | Chugai Pharmaceutical Co Ltd | Genes coding for megakaryocyte potentiator |
| EE9600121A (et) * | 1994-03-31 | 1997-04-15 | Amgen Inc. | Megakarüotsüütide kasvu ja diferentseerumist stimuleerivad kompositsioonid ja meetodid |
| US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
| US7375183B1 (en) * | 1996-01-05 | 2008-05-20 | The United States Of America As Represented By The Department Of Health And Human Services | Mesothelin, immunogenic peptides derived therefrom, and compositions comprising mesothelin, or immunogenic peptides thereof |
| WO1997025068A2 (en) * | 1996-01-05 | 1997-07-17 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Mesothelin antigen and methods and kits for targeting it |
| US6809184B1 (en) * | 1997-12-01 | 2004-10-26 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| US6589759B1 (en) | 1999-03-30 | 2003-07-08 | Trustees Of Boston University | Compositions and methods for producing platelets and/or proplatelets from megakaryocytes |
| MXPA01011950A (es) | 1999-05-27 | 2002-05-06 | Gov Health & Human Serv | Inmunoconjugados que tienen alta afinidad de enlace. |
| US20090110702A1 (en) * | 2002-07-12 | 2009-04-30 | The Johns Hopkins University | Mesothelin Vaccines and Model Systems and Control of Tumors |
| US9200036B2 (en) | 2002-07-12 | 2015-12-01 | The Johns Hopkins University | Mesothelin vaccines and model systems |
| US20050175625A1 (en) * | 2002-07-12 | 2005-08-11 | The Johns Hopkins University | Mesothelin vaccines and model systems |
| US20040180387A1 (en) * | 2003-03-13 | 2004-09-16 | Fujirebio Diagnostics, Inc. | Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| HRP20150074T1 (hr) | 2007-10-01 | 2015-03-13 | Bristol-Myers Squibb Company | Humana antitijela koja se vežu za mezotelin i njihove uporabe |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05247095A (ja) * | 1990-12-28 | 1993-09-24 | Asahi Chem Ind Co Ltd | 新規な巨核球増幅因子とその製造方法および医薬組成物 |
| JPH04295500A (ja) * | 1991-03-26 | 1992-10-20 | Asahi Chem Ind Co Ltd | 新規な巨核球増幅因子とその製法 |
-
1992
- 1992-12-22 JP JP34215192A patent/JP3328341B2/ja not_active Expired - Fee Related
- 1992-12-24 EP EP93900384A patent/EP0621285B1/en not_active Expired - Lifetime
- 1992-12-24 US US08/256,133 patent/US5498698A/en not_active Expired - Lifetime
- 1992-12-24 AU AU31721/93A patent/AU658040B2/en not_active Expired
- 1992-12-24 DE DE69232698T patent/DE69232698T2/de not_active Expired - Lifetime
- 1992-12-24 AT AT93900384T patent/ATE221084T1/de active
- 1992-12-24 CA CA002126680A patent/CA2126680C/en not_active Expired - Lifetime
- 1992-12-24 ES ES93900384T patent/ES2180542T3/es not_active Expired - Lifetime
- 1992-12-24 TW TW081110384A patent/TW224975B/zh not_active IP Right Cessation
- 1992-12-24 KR KR1019940702233A patent/KR100233701B1/ko not_active Expired - Lifetime
- 1992-12-24 WO PCT/JP1992/001689 patent/WO1993013132A1/ja not_active Ceased
- 1992-12-27 CN CN92113842A patent/CN1075148A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05331200A (ja) | 1993-12-14 |
| KR100233701B1 (ko) | 1999-12-01 |
| AU658040B2 (en) | 1995-03-30 |
| KR940703858A (ko) | 1994-12-12 |
| WO1993013132A1 (fr) | 1993-07-08 |
| CA2126680C (en) | 2002-10-08 |
| US5498698A (en) | 1996-03-12 |
| ES2180542T3 (es) | 2003-02-16 |
| AU3172193A (en) | 1993-07-28 |
| DE69232698D1 (de) | 2002-08-29 |
| EP0621285A4 (en) | 1995-05-24 |
| EP0621285A1 (en) | 1994-10-26 |
| TW224975B (enExample) | 1994-06-11 |
| EP0621285B1 (en) | 2002-07-24 |
| CN1075148A (zh) | 1993-08-11 |
| DE69232698T2 (de) | 2003-03-20 |
| CA2126680A1 (en) | 1993-07-08 |
| JP3328341B2 (ja) | 2002-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69232698D1 (de) | Neuer megakaryocyten-verstärker | |
| ATE238345T1 (de) | Protegrine | |
| ATE209215T1 (de) | Protegrine | |
| DE59007517D1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung. | |
| ATE219103T1 (de) | Cnp-analoge peptide und ihre verwendung | |
| DK0656945T3 (da) | Stressproteinepitoper | |
| ATE171712T1 (de) | Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten | |
| EP0662516A4 (en) | NEW ELAFINE DERIVATIVE. | |
| DE69018926D1 (de) | Vakzine gegen Bordetella. | |
| EP0796867A4 (en) | Peptide, bronchodilator and blood flow ameliorant | |
| DE68910382D1 (de) | Oxabicycloalkan-ether als Herbizide. | |
| DK1005487T3 (da) | Ydre 74 kD-membranprotein fra Moraxella catarrhalis | |
| ES2103792T3 (es) | Factor de crecimiento de union a la heparina. | |
| ATE116336T1 (de) | Bakteriozin-peptid. | |
| AU628653B2 (en) | Novel cns-active hexapeptides with an antiamnesic effect | |
| SE8904188D0 (sv) | Chromogenic substrate | |
| SE9101586D0 (sv) | Modified thioredoxin and its use | |
| ATE119779T1 (de) | Verwendung von 5'-vinylhalo- aristeromycin/adenosin-analoga als immunsuppressiva. | |
| ECSP972344A (es) | Proteinas antiobesidad |